Found: 7
Select item for more details and to access through your institution.
Food and Drug Administration Public Workshop Summary—Addressing Challenges in Inhaled Antifungal Drug Development.
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 6, p. 1564, doi. 10.1093/cid/ciad607
- By:
- Publication type:
- Article
Food and Drug Administration Public Workshop Summary—Development Considerations of Antifungal Drugs to Address Unmet Medical Need.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, n. 3, p. 380, doi. 10.1093/cid/ciad195
- By:
- Publication type:
- Article
Streamlining Safety Data Collection in Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia Trials: Recommendations of the Clinical Trials Transformation Initiative Antibacterial Drug Development Project Team.
- Published in:
- Clinical Infectious Diseases, 2016, v. 63, p. S39, doi. 10.1093/cid/ciw316
- By:
- Publication type:
- Article
Toward Earlier Inclusion of Pregnant and Postpartum Women in Tuberculosis Drug Trials: Consensus Statements From an International Expert Panel.
- Published in:
- Clinical Infectious Diseases, 2016, v. 62, n. 6, p. 761, doi. 10.1093/cid/civ991
- By:
- Publication type:
- Article
Authorization of Vaccines in the European Union.
- Published in:
- Molecular Frontiers Journal, 2021, v. 5, n. 1/2, p. 58, doi. 10.1142/S2529732521400034
- By:
- Publication type:
- Article
TOXOPLASMOZA OCULARĂ.
- Published in:
- Romanian Journal of Infectious Diseases / Revista Romana de de Boli Infectioase, 2007, v. 10, n. 4, p. 134
- By:
- Publication type:
- Article
Antimicrobial multidrug resistance in the era of COVID-19: a forgotten plight?
- Published in:
- 2021
- By:
- Publication type:
- Letter